Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/19/14 → 5/31/16 |
Funding
- Janssen Research and Development LLC: $89,932.00
13-NHL-21-JJ:(PCI-32765FLR3001) Ibrutinib combined with either BR or R-CHOP for relapsed iNHL
- Fleischman, Roger (PI)